[Treatment of pleural metastases in an interdisciplinary concept].
A retrospective examination involved 414 patients (260 m, 154 w, mean 60 y) with pleural metastasis/pleural effusion of the following primary tumors: 37.2% bronchogenic (23.2% malignant pl. mesothelioma), 14.5% breast, 8.7% adeno-ca (unknown primary) 2.4% gastrointestinal, 2.2% uterus/ovar, and 11.8% others. Thoracoscopy with histologic confirmation played a central role in our diagnostic procedures in 97% of the cases. Malignancy was defined by CEA (less than 5 mg/ml) (71.9%) and cytology (76.9%) in 90.4%. Our strategy had the following success rate: desiccation by pleural drainage (greater than 26 Charr) alone 74%, in combination with pleurodesis 81%, pleurectomy/decortication 95%, and extended pleuropneumonectomy (in 80% mesothelioma) 96%.
Branscheid
D
D
Chir. Abt. Thoraxklinik Heidelberg-Rohrbach.
Bischoff
H
H
Branscheid
C
C
Vogt-Moykopf
I
I
D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D010994:Pleura / Q000473:pathology / Q000601:surgery; D016066:Pleural Effusion, Malignant / Q000401:mortality / Q000473:pathology / Q000601:surgery; D010997:Pleural Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary* / Q000601:surgery*; D011183:Postoperative Complications / Q000401:mortality; D013396:Suction; D015996:Survival Rate; D013906:Thoracoscopy